Emmat Investments Pty. Ltd.

Status: Registered
Australian Company Number: 091467319
Australian Business Number: 66091467319
Registration date: February 4, 2000
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Emmat Investments Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2000-02-04 and was issued with the 091467319 ACN. Its Australian Business Number is 66091467319. Since 2019-02-22, the company is headquartered in NSW, post code 2300. The previous headquarters were located in NSW 2303 (from 2014-09-13 to 2019-02-22), NSW 2303 (from 2010-10-10 to 2014-09-13), and NSW 2303 (from 2000-05-26 to 2010-10-10). The above data comes from the ABN database which was updated on 2019-02-23.

Details for ABN 66091467319

Type: Australian Private Company

ABN Status

Status From To
Active November 1, 1999 current

Main Name

Name From To
Emmat Investments Pty. Ltd. August 4, 2000 current
Emmat Investments Pty Limited May 26, 2000 August 4, 2000

Main Location

Location From To
NSW 2300 February 22, 2019 current
NSW 2303 September 13, 2014 February 22, 2019
NSW 2303 October 10, 2010 September 13, 2014
NSW 2303 May 26, 2000 October 10, 2010

Advertisements

Find company

NSW 2300 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.